Clinical & translational oncology

• 

  Año 2013, Vol. 15, Número 7

  • Should be NICE have a Spanish NICE?

    Jaime Feliu Batlle, E. Espinosa Arranz

    págs. 501-502

    

  • Lung adenocarcinoma in the era of targeted therapies: histological classification, sample prioritization, and predictive biomarkers

    E. Conde Gallego, Bárbara Angulo Biedma, Elisa Izquierdo, Fernando López-Rios Moreno, Luis Paz-Ares Rodríguez, Cristóbal Belda Iniesta, Manuel Hidalgo Medina

    • Resumen

    págs. 503-508

    

  • GEICO (Spanish Group for Investigation on Ovarian Cancer) treatment guidelines in ovarian cancer 2012

    Antonio González Martín, A. Redondo Sánchez, Matías Jurado Chacón, Ana de Juan Ferré, Ignacio Romero Noguera, Isabel Bover Barceló, Josep Maria del Campo Fornis, Andrés Cervantes Ruiperez, Yolanda García García, José Antonio López Guerrero, César Mendiola Fernández, José Palacios Calvo, María Jesús Rubio Pérez, Andrés Poveda

    • Resumen

    págs. 509-525

    

  • Optimal management of breakthrough cancer pain (BCP)

    Yolanda Escobar Álvarez, Ana Mañas Rueda, Joaquim Julià Torras, Rafael Gálvez Mateos, Francisco Zaragoza Arnáez, César Margarit Ferri, Rafael López López, A. M. Casas Fernández de Tejerina, A. Antón Torres, Juan Jesús Cruz Hernández

    • Resumen

    págs. 526-534

    

  • Comparison of second-line treatment outcomes between sensitive and refractory small cell lung cancer patientss: a retrospective analysis

    T. Korkmaz, S. Seber, U. Kefeli, E. Sari, M. Canhoroz, Basak Oven Ustaalioglu, Mahmut Gumus, E. Yildirim, N. Yasar, D. Aydin, O. Balvan, N. Sener, S. Yuksel, A. Mert, O. Polat, F. Yumuk, Ozkan Kanat, N. S. Turhal

    • Resumen

    págs. 535-540

    

  • Increased expression of CD24 is associated with tumor progression and prognosis in patients suffering osteosarcoma

    J. Tang, H. Cai, L. Lin, P. Xie, W. Zhong, M. Tang

    • Resumen

    págs. 541-547

    

  • Management and outcome of ovarian malignancy complicating pregnancy: an analysis of 41 cases and review of the literature

    T. Gui, D. Cao, Keng Shen, Jiaxin Yang, C. Fu, J. Lang, X. Liu

    • Resumen

    págs. 548-554

    

  • Association of BRCA1 promoter methylation with rs11655505 (c.2265C>T) variants and decreased gene expression in sporadic breast cancer

    Tarique N. Hasan, B. Leena Grace, Gowhar Shafi, Rabbani Syed

    • Resumen

    págs. 555-562

    

  • Altered expression of piRNAs and their relation with clinicopathologic features of breast cancer

    Guan-li Huang, H. Hu, X. Xue, S. Shen, Er-li Gao, G. Guo, X. Shen, X. Zhang

    • Resumen

    págs. 563-568

    

  • Upregulation of microRNA-224 confers a poor prognosis in glioma patients

    S. Lu, S. Wang, S. Geng, S. Ma, Z. Liang, B. Jiao

    • Resumen

    págs. 569-574

    

  • Persistent elevated C-reactive protein after treatment is an independent marker of a poor prognosis in patients with hepatocellular carcinoma

    N. Imai, A. Kinoshita, H. Onoda, A. Iwaku, M. Oishi, K. Tanaka, N. Fushiya, K. Koike, H. Nishino, H. Tajiri

    • Resumen

    págs. 575-581

    

  • Lack of Bax expression is associated with irinotecan-based treatment activity in advanced colorectal cancer patients

    F. Pietrantonio, P. Biondani, M. Milione, F. Melotti, G. Bertarelli, F. Perrone, F. de Braud, L. Mariani, G. Fanetti, D. Cortinovis, M. Di Bartolomeo

    • Resumen

    págs. 582-586